This potent inhibitor stands as a promising hippo target in leukaemia and MM cell lines expressing abnormal serine/threonine-protein kinases 3 (STK3/MST2) and 4 (STK4/MST1) expressions [26]. This evidence concerns the gene STK3 and Miyoshi myopathy.